necrosis$51926$ - ορισμός. Τι είναι το necrosis$51926$
Display virtual keyboard interface

Τι (ποιος) είναι necrosis$51926$ - ορισμός

MEDICAL CONDITION
Warfarin induced skin necrosis; Anticoagulant-induced skin necrosis; Anticoagulant induced skin necrosis; Coumadin necrosis; Coumarin necrosis

Liquefactive necrosis         
TYPE OF NECROSIS WHICH RESULTS IN A TRANSFORMATION OF THE TISSUE INTO A LIQUID VISCOUS MASS
Colliquative necrosis
Liquefactive necrosis (or colliquative necrosis) is a type of necrosis which results in a transformation of the tissue into a liquid viscous mass.Robbins and Cotran: Pathologic Basis of Disease, 8th Ed.
Renal cortical necrosis         
RARE CAUSE OF ACUTE KIDNEY FAILURE
Acute Cortical Necrosis; Diffuse Cortical Necrosis; Renal Cortical Necrosis; Diffuse bilateral renal cortical necrosis
Renal cortical necrosis (RCN) is a rare cause of acute kidney failure. The condition is "usually caused by significantly diminished arterial perfusion of the kidneys due to spasms of the feeding arteries, microvascular injury, or disseminated intravascular coagulation" and is the pathological progression of acute tubular necrosis.
Acute tubular necrosis         
MEDICAL CONDITION INVOLVING THE DEATH OF TUBULAR EPITHELIAL CELLS THAT FORM THE RENAL TUBULES OF THE KIDNEYS
Tubular necrosis; Muddy-brown cast; Tubulorrhexis; Acute Tubular Necrosis
Acute tubular necrosis (ATN) is a medical condition involving the death of tubular epithelial cells that form the renal tubules of the kidneys. Because necrosis is often not present, the term acute tubular injury (ATI) is preferred by pathologists over the older name acute tubular necrosis (ATN).

Βικιπαίδεια

Warfarin necrosis

Warfarin-induced skin necrosis is a condition in which skin and subcutaneous tissue necrosis (tissue death) occurs due to acquired protein C deficiency following treatment with anti-vitamin K anticoagulants (4-hydroxycoumarins, such as warfarin).

Warfarin necrosis is a rare but severe complication of treatment with warfarin or related anticoagulants. The typical patient appears to be an obese, middle aged woman (median age 54 years, male to female ratio 1:3).: 122–3  This drug eruption usually occurs between the third and tenth days of therapy with warfarin derivatives. The first symptoms are pain and redness in the affected area. As they progress, lesions develop a sharp border and become petechial, then hard and purpuric. They may then resolve or progress to form large, irregular, bloody bullae with eventual necrosis and slow-healing eschar formation. Favored sites are breasts, thighs, buttocks and penis, all areas with subcutaneous fat.: 122  In rare cases, the fascia and muscle are involved.

Development of the syndrome is associated with the use of large loading doses at the start of treatment.